Page last updated: 2024-09-02

quinaprilat and pd 123319

quinaprilat has been researched along with pd 123319 in 1 studies

Compound Research Comparison

Studies
(quinaprilat)
Trials
(quinaprilat)
Recent Studies (post-2010)
(quinaprilat)
Studies
(pd 123319)
Trials
(pd 123319)
Recent Studies (post-2010) (pd 123319)
922348946175

Protein Interaction Comparison

ProteinTaxonomyquinaprilat (IC50)pd 123319 (IC50)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.21
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.21
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.21

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP1

Other Studies

1 other study(ies) available for quinaprilat and pd 123319

ArticleYear
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

2002